Carna Biosciences (TSE:4572) Total Receivables: 円100.5 Mil (As of Dec. 2025)


TSE:4572 Carna Biosciences Inc TSE:4572
34 GF Score
Price 円362.00
GF Value 円188.26
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Total Receivables?

Carna Biosciences TSE:4572 +4.02% 34 Total Receivables is 円100.5 Mil as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 34/100 and a GF Value™ of 円188.26 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Carna Biosciences's Total Receivables for the quarter that ended in Dec. 2025 was 円100.5 Mil.


Carna Biosciences Total Receivables Related Terms


Carna Biosciences Total Receivables Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Total Receivables Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,243.84 182.43 788.20 87.09 100.53

Carna Biosciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.27 71.94 71.17 100.53 117.57
TSE:4572
34GF Score
Carna Biosciences Inc TSE:4572
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of 円100.5 Mil mean?
Carna Biosciences (TSE:4572) has a Total Receivables of 円100.5 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Carna Biosciences and its competitors.
Is Carna Biosciences' Total Receivables too high?
Carna Biosciences' current Total Receivables is 円100.5 Mil. Overall, Carna Biosciences has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Total Receivables compare to VRTX and REGN?
Carna Biosciences' Total Receivables of 円100.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Total Receivables is 円100.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円188.26, compared to a current price of 円362.00 — trading 92.3% above its estimated fair value. The current Total Receivables is 円100.5 Mil. Carna Biosciences' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Total Receivables is 円100.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円362.00 is trading 92.3% above its estimated GF Value™ of 円188.26. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Total Receivables: 円100.5 Mil
  • GF Value™: 円188.26 vs. price of 円362.00 (92.3% above fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
34GF Score

Get the complete analysis for TSE:4572

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円362.00
Price
円188.26
GF Value